On Being the Right Size: The Impact of Population Size and Stochastic Effects on the Evolution of Drug Resistance in Hospitals and the Community

English version České info

The evolution of drug resistant bacteria is a severe public health problem, both in hospitals and in the community. Currently, some countries aim at concentrating highly specialized services in large hospitals in order to improve patient outcomes. Emergent resistant strains often originate in health care facilities, but it is unknown to what extent hospital size affects resistance evolution and the resulting spillover of hospital-associated pathogens to the community. We used two published datasets from the US and Ireland to investigate the effects of hospital size and controlled for several confounders such as antimicrobial usage, sampling frequency, mortality, disinfection and length of stay. The proportion of patients acquiring both sensitive and resistant infections in a hospital strongly correlated with hospital size. Moreover, we observe the same pattern for both the percentage of resistant infections and the increase of hospital-acquired infections over time. One interpretation of this pattern is that chance effects in small hospitals impede the spread of drug-resistance. To investigate to what extent the size distribution of hospitals can directly affect the prevalence of antibiotic resistance, we use a stochastic epidemiological model describing the spread of drug resistance in a hospital setting as well as the interaction between one or several hospitals and the community. We show that the level of drug resistance typically increases with population size: In small hospitals chance effects cause large fluctuations in pathogen population size or even extinctions, both of which impede the acquisition and spread of drug resistance. Finally, we show that indirect transmission via environmental reservoirs can reduce the effect of hospital size because the slow turnover in the environment can prevent extinction of resistant strains. This implies that reducing environmental transmission is especially important in small hospitals, because such a reduction not only reduces overall transmission but might also facilitate the extinction of resistant strains. Overall, our study shows that the distribution of hospital sizes is a crucial factor for the spread of drug resistance.

Vyšlo v časopise: On Being the Right Size: The Impact of Population Size and Stochastic Effects on the Evolution of Drug Resistance in Hospitals and the Community. PLoS Pathog 7(4): e32767. doi:10.1371/journal.ppat.1001334
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001334

Souhrn

Zdroje

1. ChambersHF

DeleoFR

2009 Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 7 629 641

2. NeuhauserMM

WeinsteinRA

RydmanR

DanzigerLH

KaramG

2003 Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 289 885 888

3. Abel zur WieschP

KouyosR

EngelstädterJ

RegoesR

BonhoefferS

2011 Population biological principles of drug-resistance evolution in infectious diseases. Lancet Infect Dis 11 235 247

4. SmithDL

LevinSA

LaxminarayanR

2005 Strategic interactions in multi-institutional epidemics of antibiotic resistance. Proc Natl Acad Sci U S A 102 3153 3158

5. NicolleL

2001 Infection control programmes to contain antimicrobial resistance. WHO Available: http://www.who.int/csr/resources/publications/drugresist/infection_control.pdf

6. DeleoFR

OttoM

KreiswirthBN

ChambersHF

2010 Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375 1557 1568

7. OpatowskiL

MandelJ

VaronE

BoellePY

TemimeL

2010 Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamics. Antimicrob Agents Chemother 54 2330 2337

8. GoossensH

FerechM

Vander SticheleR

ElseviersM

2005 Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365 579 587

9. AsensioA

CantonR

VaqueJ

RosselloJ

CalboF

2006 Nosocomial and community-acquired meticillin-resistant Staphylococcus aureus infections in hospitalized patients (Spain, 1993-2003). J Hosp Infect 63 465 471

10. BhavnaniSM

HammelJP

ForrestA

JonesRN

AmbrosePG

2003 Relationships between patient- and institution-specific variables and decreased antimicrobial susceptibility of Gram-negative pathogens. Clin Infect Dis 37 344 350

11. ChastreJ

2008 Evolving problems with resistant pathogens. Clin Microbiol Infect 14 Suppl 3 3 14

12. PoirelL

NordmannP

2006 Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 12 826 836

13. ZoutmanDE

FordBD

2005 The relationship between hospital infection surveillance and control activities and antibiotic-resistant pathogen rates. Am J Infect Control 33 1 5

14. de WithK

MeyerE

Steib-BauertM

SchwabF

DaschnerFD

2006 Antibiotic use in two cohorts of German intensive care units. J Hosp Infect 64 231 237

15. BergstromCT

LoM

LipsitchM

2004 Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci U S A 101 13285 13290

16. BonhoefferS

LipsitchM

LevinBR

1997 Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci U S A 94 12106 12111

17. GillespieDT

2001 Approximate accelerated stochastic simulation of chemically reacting systems. J Chem Phys 115 1716 1733

18. GillespieDT

1976 General Method for Numerically Simulating Stochastic Time Evolution of Coupled Chemical-Reactions. J Comput Phys 22 403 434

19. Health Service Executive Ireland 2011 Healthcare-Associated Infection and Antimicrobial Resistance-Related Data from Acute Public Hospitals in Ireland, 2006-2007. Available: http://www.hse.ie/eng/services/newscentre/2008_Archive/May_2008/HSE_publishes_Health_Care_Associated_Infection_statistics.html

20. Pennsylvania Health Care Cost Containment Council 2011 Hospital-acquired Infections in Pennsylvania 2005, 2006 & 2007. Available: http://www.phc4.org/reports/hai/

21. FisherRA

1930 The Genetical Theory of Natural Selection. Oxford Clarendon Press

22. NeelyAN

MaleyMP

2000 Survival of enterococci and staphylococci on hospital fabrics and plastic. J Clin Microbiol 38 724 726

23. Leverstein-van HallMA

BlokHE

PaauwA

FluitAC

TroelstraA

2006 Extensive hospital-wide spread of a multidrug-resistant enterobacter cloacae clone, with late detection due to a variable antibiogram and frequent patient transfer. J Clin Microbiol 44 518 524

24. AhgrenB

2008 Is it better to be big? The reconfiguration of 21st century hospitals: Responses to a hospital merger in Sweden. Health Policy 87 92 99

25. KeelerEB

RubensteinLV

KahnKL

DraperD

HarrisonER

1992 Hospital Characteristics and Quality of Care. JAMA 268 1709 1714

26. McCallionG

GlassJC

JacksonR

KerrCA

McKillopDG

2000 Investigating productivity change and hospital size: a nonparametric frontier approach. Appl Econ 32 161 174

27. CarrBG

GoyalM

BandRA

GaieskiDF

AbellaBS

2009 A national analysis of the relationship between hospital factors and post-cardiac arrest mortality. Intensive Care Med 35 505 511

28. LucianiF

SissonSA

JiangH

FrancisAR

TanakaMM

2009 The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 106 14711 14715

29. JohnsenPJ

TownsendJP

BohnT

SimonsenGS

SundsfjordA

2011 Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures. J Antimicrob Chemother 66 608 610

30. TrindadeS

SousaA

XavierKB

DionisioF

FerreiraMG

2009 Positive epistasis drives the acquisition of multidrug resistance. PLoS Genet 5 e1000578

31. HartlDL

ClarkAG

2007 Principles of Population Genetics. Sunderland Sinauer Associates

32. LucetJC

PaolettiX

DemontpionC

DegraveM

VanjakD

2009 Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members. Arch Intern Med 169 1372 1378

33. van LoonHJ

VriensMR

FluitAC

TroelstraA

van der WerkenC

2005 Antibiotic rotation and development of gram-negative antibiotic resistance. Am J Respir Crit Care Med 171 480 487

34. CarsO

MolstadS

MelanderA

2001 Variation in antibiotic use in the European Union. Lancet 357 1851 1853